Eiko Lifesciences Ltd Intrinsic Value
EIKO · Commodities · Current price ₹49.27
Is Eiko Lifesciences Ltd undervalued?
DocStoX estimates the fair value of Eiko Lifesciences Ltd at ₹35 per share, versus the current market price of ₹49. That puts the stock about -29.4% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹43), Relative P/E (₹27), Graham floor (₹25). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹25 (bear) to ₹35 (base) to ₹43 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹49 versus an intrinsic value of ₹35, Eiko Lifesciences Ltd currently offers -29.4% of negative margin (i.e. a premium).
More on Eiko Lifesciences Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.